Track topics on Twitter Track topics that are important to you
What is GENOTROPIN? GENOTROPIN (somatropin [rDNA origin] for injection) is a growth hormone treatment. It is an exact copy of the natural growth hormone that our bodies make. The main difference i...
Follicle-stimulating hormone (FSH) now has become an established means of ovulation induction (OI) as part of assisted reproductive technology (ART). FSH is used to induce development of multiple foll...
US biotech OPKO Health has said it will continue with clinical development of its long-acting human growth hormone product (hGH-CTP), even though it has failed in a late stage trial in adult growth ho...
Growth hormone derivative somapacitan and recombinant human growth hormone somavaratan both produce data suggesting weekly or even biweekly dosing is safe and effective. Medscape Medical News
Recombinant human growth hormone (rhGH) is a potential novel therapy for fibrogenesis imperfecta ossium (FIO), a very rare but disabling and ultimately fatal bone disease, a small study from India sug...
OPKO Health’s weekly growth hormone injection could be approvable in adults without need for further clinical trials, the company has told pharmaphorum. The biotech has worked with Pfizer to co-dev...
A new study examines how the sex hormone estrogen affects gene regulation in the brain, affecting the formation of fear memories and PTSD.
NewsA new trial may hold new hope for military personnel through treatment with oxytocin, sometimes referred to as the “love hormone.”
OPKO Health said today that the long-acting human growth hormone candidate hGH-CTP, which is being developed in adults with growth hormone deficiency under a collaboration with Pfizer, has failed a Ph...
Growth hormone replacement therapy may help improve physical function and quality of life among GH-deficient adults. Clinical Endocrinology
To extend available dosing options in the treatment of growth hormone deficiency, a comparative pharmacokinetic and pharmacodynamic phase-1 clinical study involving subcutaneous administration of grow...
Daily subcutaneous injection of human growth hormone has been used for the treatment of growth hormone deficiency and growth failure but has led to poor patient compliance and renal toxicity. Thus, it...
MOD-4023 is a long-acting human growth hormone (hGH) in clinical trials for the treatment of growth hormone deficiency (GHD). A key goal is maintenance of serum concentrations of insulin-like growth f...
TV-1106 is a recombinant human albumin genetically fused to growth hormone which is intended to reduce the frequency of injections for GH therapy users. We report the safety, tolerability, pharmacokin...
This study is a first time assessment of safety and tolerability, pharmacokinetics, and pharmacodynamics of RO5046013 in human, in comparison with unmodified rhIGF-I.